In draft guidance, the agency has said that while Keytruda (pembrolizumab) added to chemotherapy is more effective than chemo alone. Its long-term benefits are uncertain. Moreover, NICE says there ...

Keytruda (pembrolizumab) is a prescription drug that’s used to treat certain forms of cancer. Keytruda comes as an intravenous (IV) infusion (an injection into your vein given over time).

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

Prostate cancer has proved an elusive target for cancer immunotherapies, and Merck & Co's checkpoint inhibitor Keytruda is the ... with considerable side effects that forced a change in dosing ...

At the conference, Merck revealed findings from the KeyNOTE-522 study, which assessed the effectiveness of Keytruda combined ...

Lastly, the growing success of Keytruda has increased the firm's dependence on the drug for growth, which could become problematic if any side effects show up or new therapies emerge quickly in ...

Notably, 20.8% of patients who received ivonescimab experienced serious treatment-related side effects vs. 16.1% of Keytruda ...

IO Biotech (IOBT) announced data from the NSCLC cohort in the company’s Phase 2 basket trial of IO102-IO103, the company’s lead investigational candidate, given in combination with Merck’s anti-PD-1 ...